Scholarly Index
Carmela R. Abraham
Advantagene (United States); 13,685 total citations; 167 total publications; best world rank #257
Advantagene (United States)
13,685Total citations
167Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Alzheimer's disease research and treatments | Lifetime | 756 | US 369 | 98.13 |
| Parathyroid Disorders and Treatments | Lifetime | 459 | US 191 | 97.21 |
| Genetic Syndromes and Imprinting | Lifetime | 339 | US 137 | 95.97 |
| S100 Proteins and Annexins | Lifetime | 486 | US 223 | 95.62 |
| Genetic and Kidney Cyst Diseases | Lifetime | 668 | US 291 | 92.67 |
| Nuclear Receptors and Signaling | Lifetime | 806 | US 346 | 90.61 |
| Prion Diseases and Protein Misfolding | Lifetime | 919 | US 303 | 89.47 |
| Genetic Syndromes and Imprinting | 2021-2025 | 257 | US 78 | 80.57 |
| Parathyroid Disorders and Treatments | 2021-2025 | 836 | US 217 | 80.47 |